These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

906 related items for PubMed ID: 16802544

  • 1. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V, Floege J.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():158-62. PubMed ID: 16802544
    [Abstract] [Full Text] [Related]

  • 2. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 22; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 3. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Nov 22; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 4. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May 22; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 5. [Epidemiology of CKD in Japan].
    Iseki K.
    Nihon Rinsho; 2008 Sep 22; 66(9):1650-6. PubMed ID: 18788390
    [Abstract] [Full Text] [Related]

  • 6. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group.
    Exp Gerontol; 2008 Apr 22; 43(4):347-52. PubMed ID: 18294794
    [Abstract] [Full Text] [Related]

  • 7. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar 22; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 8. [Advances in detection, evaluation and management of chronic kidney disease].
    Indridason OS, Thorsteinsdóttir I, Pálsson R.
    Laeknabladid; 2007 Mar 22; 93(3):201-7. PubMed ID: 17341799
    [Abstract] [Full Text] [Related]

  • 9. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M, Paoletti E.
    Ital Heart J Suppl; 2004 Jun 22; 5(6):436-44. PubMed ID: 15471148
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of glomerular filtration rate and proteinuria for the diagnosis of chronic kidney disease].
    Groupe de travail de la Société de Néphrologie.
    Nephrol Ther; 2009 Jul 22; 5(4):302-5. PubMed ID: 19406695
    [Abstract] [Full Text] [Related]

  • 11. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 22; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 12. Early diagnosis of CKD and its prevention.
    Amaresan MS, Geetha R.
    J Assoc Physicians India; 2008 Jan 22; 56():41-6. PubMed ID: 18472500
    [Abstract] [Full Text] [Related]

  • 13. Chronic kidney disease and global cardiovascular risk in essential hypertension.
    Segura J, Campo C, Ruilope LM.
    Minerva Med; 2004 Oct 22; 95(5):375-83. PubMed ID: 15467513
    [Abstract] [Full Text] [Related]

  • 14. Detection and evaluation of chronic kidney disease.
    Snyder S, Pendergraph B.
    Am Fam Physician; 2005 Nov 01; 72(9):1723-32. PubMed ID: 16300034
    [Abstract] [Full Text] [Related]

  • 15. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 01; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 16. Screening for chronic kidney disease: which strategy?
    Hallan SI, Stevens P.
    J Nephrol; 2010 Jun 01; 23(2):147-55. PubMed ID: 20155721
    [Abstract] [Full Text] [Related]

  • 17. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T, Gejyo F.
    Nihon Rinsho; 2007 Sep 01; 65(9):1727-33. PubMed ID: 17877002
    [Abstract] [Full Text] [Related]

  • 18. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A, CKD-JAC Study Group.
    Hypertens Res; 2008 Jun 01; 31(6):1101-7. PubMed ID: 18716357
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.
    Ren Fail; 2008 Jun 01; 30(6):625-8. PubMed ID: 18661413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.